TRANSCAT INC (TRNS)
Instruments For Meas & Testing of Electricity & Elec Signals · Healthcare · $846M
Intrinsic Value (Consensus)
$19.43
Current Price
$90.63
Margin of Safety
-78.6%
78.6% Above Intrinsic Value
Value: $19
Price: $91
Valuation Model Estimates
Current Price: $90.63
DCF (Discounted Cash Flow)
$26.56
Graham Number
$20.32
Earnings Power Value
$5.53
Relative Value (P/E)
$11.40
Dividend Discount Model
Not applicable
—
Consensus Value
$19.43
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
54
Profitability
12/25
Strength
22/25
Valuation
7/25
Growth
13/25
Key Financials
- EPS (TTM)
- $0.57
- EPS (Forward)
- $0.58
- Book Value
- $32.21
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 1.8%
- Debt/Equity
- 33%
- Revenue Growth
- 19.2%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance